Navigation Links
Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
Date:2/19/2008

NEW YORK, Feb. 19 /PRNewswire-FirstCall/ -- Cowen Group, Inc. (Nasdaq: COWN) and Cowen Healthcare Royalty Partners ("CHRP") announced today that Matthew Q. Reber has been hired as Vice President, effective immediately.

Mr. Reber is based in Connecticut and rejoins founders Gregory B. Brown, Todd C. Davis and Clarke B. Futch, the Managing Directors of CHRP, with whom he previously worked at Paul Capital Partners.

Prior to joining CHRP, Mr. Reber worked at Accretive LLC, a private investment firm. Previously, he was an associate at Paul Capital Partners in the Paul Royalty Funds, which he joined in 2005 after having been a summer associate. In addition to royalty-based investing, Matt has significant healthcare experience across a broad range of transactions, including private equity investments, public and private financings, advisory transactions and structured finance. Prior to Paul Capital Partners, Mr. Reber was an investment professional focused on the healthcare industry at Oak Hill Capital Partners and J.H. Whitney & Co. and a healthcare investment banker at Morgan Stanley.

Matt earned his MBA with honors from The Wharton School of the University of Pennsylvania, his Master of Biotechnology from The University of Pennsylvania and his BSE, magna cum laude, from Princeton University.

"We are excited to have Matt rejoin us and further strengthen our team. We are confident that his extensive experience in the health care industry, combined with his strong transactional background will enhance the capabilities and leadership of our firm," said Todd C. Davis, Co-founder and Managing Director of CHRP.

Since its inception, CHRP has continued to build and strengthen its team. In January, CHRP also announced the promotion of Paul J. Hadden to Vice President and John A. Urquhart to Associate.

About Cowen Healthcare Royalty Partners

Cowen Healthcare Royalty Partners manages an investment program that invests principally in commercial-stage biopharmaceutical products and companies. CHRP seeks to invest in companies and acquires royalty interests in end-user sales of commercial-stage, or near commercial-stage medical products such as pharmaceuticals, biotechnology products and medical devices. CHRP, based in Stamford, CT, is led by a team of investors who bring complementary skills and backgrounds to bear on the evaluation and execution of these investments.

For further information, contact:

Cowen Healthcare Royalty Partners

177 Broad St., Suite 1101

Stamford, CT 06901

(646) 562-1000

http://www.cowenroyalty.com

About Cowen Group, Inc.

Cowen Group, Inc., through Cowen and Company, LLC and Cowen International Limited, provides investment banking services, including underwriting and other capital raising solutions, equity research, sales, trading and mergers and acquisitions advice, to emerging growth companies in sectors including healthcare, technology, media and telecommunications and consumer.


'/>"/>
SOURCE Cowen Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
2. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
3. The Ensign Group, Inc. Declares Quarterly Dividend of $0.04 Per Share
4. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
5. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
6. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
7. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
8. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
9. MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 2008 UBS Healthcare Services Conference
10. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
11. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ... April 20, 2017 , ... NetDimensions appoints Bill Mastin, a learning technology veteran, ... of experience in the learning technologies industry, Mastin joins NetDimensions from the New York ... plc (LTG). At LEO, Mastin served as SVP of the North America offices and ...
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... ... formation of a unique intellectual property (IP) sharing and commercialization model. , The ... promising inventions. A main component of this effort is bringing the IP to ...
(Date:4/19/2017)... ... ... The Vibrating Orifice Aerosol Generator (VOAG) was developed in ... known diameters for research applications such as for calibrating droplet measuring instruments, for ... , The VOAG requires forcing liquid out of an orifice about half ...
(Date:4/19/2017)... , ... April 19, 2017 , ... Nobilis Therapeutics ... , Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder ... of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):